Publications by authors named "David L Emerson"

Claim this Profile
T
TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
Daniel P Fitzgerald, David L Emerson, Yongzhen Qian, Talha Anwar, David J Liewehr

Mol Cancer Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.
Andrew J Garton, Andrew P A Crew, Maryland Franklin, Andrew R Cooke, Graham M Wynne, David L Emerson

Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice.
John Desjardins, David L Emerson, Dorothy B Colagiovanni, Elizabeth Abbott, Eric N Brown

J Pharmacol Exp Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL.
Blake Tomkinson, Ray Bendele, Francis J Giles, Eric Brown, Atherton Gray, David L Emerson

Leuk Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis